Global Cord Blood Corporation
NYSE: CO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ting Zheng
- Employees
- 1,202
- Headquarters
- Central, Hong Kong SAR China
- IPO year
- 2007
- Market cap
- $400.1M
- Website
- https://www.globalcordbloodcorp.com
Loading CO…
Loading profile data…Frequently asked questions about CO
What does Global Cord Blood Corporation (CO) do?
Global Cord Blood Corporation (GCBC), alongside its associated entities, provides specialized services related to umbilical cord blood within the People's Republic of China. The company's operations involve the testing, processing, and long-term storage of cord blood for both private subscribers and donated samples. For the latter, it also facil...
Where does CO trade?
Global Cord Blood Corporation (CO) trades on the New York Stock Exchange.
What sector is CO in?
Global Cord Blood Corporation (CO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Global Cord Blood Corporation?
Ting Zheng is the chief executive officer of Global Cord Blood Corporation (CO).
Where is Global Cord Blood Corporation headquartered?
Global Cord Blood Corporation is headquartered in Hong Kong SAR China.
Does CO pay a dividend?
Yes — Global Cord Blood Corporation (CO) paid a trailing twelve-month dividend of USD 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CO go public?
Global Cord Blood Corporation (CO) completed its initial public offering in 2007.